Background: Amyloidosis results from the accumulation of unique extracellular proteins which are not able to be degraded via the usual mechanism of lysosomal proteolysis. Isolated collections of amyloid within the bladder are extremely uncommon, and a cytopathologic description in voided urine has not been described to date. Methods: A retrospective review was performed at a tertiary-care hospital, and 3 patients with isolated bladder amyloidosis and corresponding voided urine specimens were identified. The following clinical data were collected for each case: age, gender, treatment and follow-up information. Results: The patient age range was 76-84 years, with 2 males and 1 female. Amyloidosis was never clinically suspected. In 1 patient, a urinary amyloid manifested, which was thought to represent extraneous debris at the time of original diagnosis. Two patients never manifested signs of systemic amyloidosis or multiple myeloma, and the third was found to have a monoclonal gammopathy. Conclusions: Our results show the difficulty of diagnosing urinary amyloid in the absence of clinical suspicion. Further, the presence of urinary amyloid is unlikely in patients with bladder amyloidosis as the cohesive nature of the protein makes spontaneous shedding uncommon. Testing for systemic amyloidosis is warranted and if the disease is localized, a favorable outcome can be expected.

Keywords:
Urine cytology, Amyloid, Bladder
1.
Borza T, Shah RB, Faerber GJ, Wolf JS: Localized amyloidosis of the upper urinary tract: a case series of three patients managed with reconstructive surgery or surveillance. J Endourol 2010;24:641-644.
2.
Garcia CA, Abell-Aleff PC, Gamb SI, Miller DV: Ultrasturctural analysis of amyloidoma. Ultrastruc Pathol 2009;33:123-127.
3.
Akram CM, Al-Marhoon S, Mathew J, Grant CS, Rao TV: Primary localized AA type amyloidosis of urinary bladder: case report of rare cause of episodic painless hamaturia. Urology 2006;68:1343.e15-1343.e17.
4.
Tirzaman O, Wahner-Roedler DL, Malek RS, Sebo TJ, Li C, Kyle RA: Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Mayo Clin Proc 2000;75:1264-1268.
5.
Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD: A primer of amyloid nomenclature. Amyloid 2007;14:179-183.
6.
Merrimen JLO, Alkhudair WK, Gupta R: Localized amyloidosis of the urinary tract: case series of nine patients. Urology 2006;67:904-909.
7.
Falk RH, Comenzo RL, Skinner M: The systemic amyloidoses. N Engl J Med 1997;337:898-909.
8.
Underwood JCE: General and Systematic Pathology. Edinburgh, Churchill Livingstone, 2000.
9.
Elkins CT, Scharschmidt TJ, Wakely PE: Amyloidomas of soft parts: diagnosis by fine-needle aspiration. Diagn Cytopathol 2012;40:E126-E130.
10.
Sahoo S, Reeves W, DeMay RM: Amyloid tumor: a clinical and cytomorphologic study. Diagn Cytopathol 2003;28:325-328.
11.
Michael CW, Naylor B: Amyloid in cytologic specimens: differential diagnosis and diagnostic pitfalls. Acta Cytol 1999;43:746-755.
12.
Korat O, Yachnis AT, Ernst CS: Cytologic detection of amyloid in duodenal and ureteral brushings. Diagn Cytopathol 1988;4:133-136.
13.
Orfilia C, Giraud P, Modesto A, Suc JM: Abdominal fat tissue aspirate in human amyloidosis: light, electron and immunofluorescence microscopic slides. Hum Pathol 1986;17:366-369.
14.
Lew W, Seymour AR: Primary amyloid tumor of the breast: case report and literature review. Acta Cytol 1985;29:7-11.
15.
Tomashefski JF, Cramer SF, Abramowsky C, Cohen AM, Horak G: Needle biopsy diagnosis of solitary amyloid nodule of the lung. Acta Cytol 1980;24:244-227.
16.
Gupta P, Hanamshetti S, Kulkarni JN: Primary amyloidosis with high grade transitional cell carcinoma of bladder: a rare case report. J Can Res Ther 2012;8:297-299.
17.
Chan ESY, NG C, Chui K, Hou S, Yip SKH: Primary bladder amyloidosis - case report of a patient with delayed upper urinary tract obstruction 3 years after the diagnosis. Amyloid 2012;17:36-38.
18.
Monge M, Chauveau D, Cordonnier C, Noel LH, Presne C, Makdassi R, Jaureguy M, Lecaque C, Renou M, Grunfeld JP, Choukroun G: Localized amyloidosis of the genitourinary tract: report of 5 new cases and review of the literature. Medicine 2011;90:212-222.
19.
Takahashi T, Miura H, Matsu-ura Y, Iwana S, Maruyama R, Harada T: Urine cytology of localized primary amyloidosis of the ureter: a case report. Acta Cytol 2005;49:319-322.
20.
Paraskevas KI, Anagnostou D, Bouris C: Anurea caused by primary amyloidosis of the lower third of the ureters, the uterovesical junction and the urinary bladder: a case report and review of the literature. Int Urol Nephrol 2004;36:339-342.
21.
Livneh A, Shtrasburg S, Martin BM, Baniel J, Gal R, Pras M: Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin. J Clin Pathol 2001;54:920-923.
22.
Auge BK, Haluszka MM: Primary amyloidosis of the bladder. J Urol 2000;163:1867-1868.
23.
Asi KH, Liepnieks JJ, Bihrle R, Benson MD: Local synthesis of amyloid fibril precursor in AL amyloidosis of the urinary tract. Amyloid 1998;5:49-54.
24.
Fujihara S, Glenner G: Primary localized amyloidosis of the genitourinary tract. Immunohistochemical study of eleven cases. Lab Invest 1981;44:55-60.
25.
Agarwal SK, Walmsley BH, Marley NJ: Primary amyloidosis of urinary bladder. J R Soc Med 1995;88:171-172.
26.
Ruffion A, Valignat C, Champetier D, Lopez JG, Perrin P, Devonec M: Long-term recurrence of primary amyloidosis of the bladder. Urology 2002;59:444i-444ii.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.